Quick Answer
HeartSciences Inc. reported Common Stock Shares Outstanding of 1.12 million shares for the year ending 2025.
- HeartSciences Inc. showed an increase of +65.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from HeartSciences Inc.'s annual report (Form 10-K), filed with the SEC on July 24, 2025.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: 8.17 million shares | Q4 2022: 8.21 million shares | Q1 2023: 8.35 million shares | Q3 2023: 10.67 million shares | Q4 2023: 11.21 million shares | Q1 2024: 63.61 million shares | Q3 2024: 906,416 shares | Q4 2024: 947,821 shares | Q1 2025: 1.03 million shares | Q2 2025: 1.12 million shares | Q3 2025: 2.28 million shares | Q4 2025: 3.07 million shares | Q1 2026: 3.18 million shares.
- Over the full 4 years of available data (2022 to 2025), HeartSciences Inc.'s Common Stock Shares Outstanding has declined by 66.3%.
- Historical annual values: Fiscal year 2025: 1.12 million shares | Fiscal year 2024: 676,598 shares | Fiscal year 2023: 101,332 shares | Fiscal year 2022: 3.32 million shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: